Status:
UNKNOWN
Effect of Simvastatin as Pulpotomy Agent in Cariously Exposed Permanent Molars
Lead Sponsor:
Postgraduate Institute of Dental Sciences Rohtak
Conditions:
Reversible Pulpitis
Eligibility:
All Genders
15-40 years
Phase:
NA
Brief Summary
The study will compare the outcome of complete pulpotomy in mature permanent mandibular molars with deep carious lesions by using Mineral Trioxide Aggregate and Simvastatin -alpha tricalcium phosphate...
Detailed Description
After a thorough history, clinical and radiographic examination with all eligibility confirmation, written informed consent will be taken from the patient after explaining the procedure, its associate...
Eligibility Criteria
Inclusion
- Patient willing to participate in the study.
- Age group of 15 to 40 years
- Mature permanent mandibular molars with reversible pulpitis (positive response on the cold test and early response as compared to the adjacent or contralateral tooth)
- Teeth exhibiting occlusal pulp exposure from primary dental caries.
- Absence of periapical lesions assessed by radiographic examination.
- Tooth demonstrating no mobility or swelling and no tenderness to percussion or palpation
Exclusion
- Primary teeth.
- Teeth with irreversible pulpitis (spontaneous pain) or pulp necrosis, chronic periodontitis, cracked tooth, internal or external resorption, calcified canals, associated with sinus tract and furcation or apical radiolucency.
- Immune-compromised, pregnant and patients with any systemic disorder.
- Patients taking statin medication.
- Failure to obtain authorization from the patient.
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2020
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04374214
Start Date
December 1 2018
End Date
June 30 2020
Last Update
May 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PGIDS
Rohtak, Haryana, India, 124001